TriSalus Life Sciences, Inc. - TLSI

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Nov 19, 2026 CEO and President P A 34,328.0 2.59 88,909.52 1,140,182.0 View
Nov 19, 2026 CEO and President P A 30,864.0 2.31 71,295.84 1,105,854.0 View
Nov 19, 2026 — P A 10,000.0 2.2 22,000.0 82,510.0 View
Nov 17, 2026 Chief Commercial Officer S D 544.0 2.43 1,321.92 127,450.0 View
Nov 16, 2026 — P A 50,000.0 2.24 112,000.0 197,555.0 View
Oct 07, 2026 Chief of Research S D 296.0 4.39 1,299.44 162,805.0 View
Oct 07, 2026 Chief Commercial Officer S D 325.0 4.39 1,426.75 127,994.0 View
Oct 07, 2026 Chief Regulatory Officer S D 316.0 4.39 1,387.24 123,794.0 View
Oct 07, 2026 CEO and President F D 2,693.0 4.38 11,795.34 1,074,990.0 View
Jul 06, 2026 Chief Financial Officer F D 14,650.0 4.46 65,339.0 261,107.0 View
Jul 01, 2026 CEO and President A A 3,990.0 3.87 15,441.3 1,077,683.0 View
Jul 01, 2026 Chief Commercial Officer A A 561.0 3.87 2,171.07 128,319.0 View
Jun 29, 2026 Chief Medical Officer A A 120,000.0 0.0 0.0 253,000.0 View
Jun 29, 2026 Chief Medical Officer A A 60,000.0 0.0 0.0 90,000.0 View